GET DAILY SIGNALSClorox (CLX) Rises +19% Over 30 Days Following Earnings Beat
Key Takeaways
- Clorox shares climbed roughly 19% over the trailing 30 days, rising from about $83.80 to a closing price of $99.96, following a stronger-than-expected fiscal first-quarter earnings report.
- The short-term rebound stands in contrast to a modest decline over the trailing three-month period, highlighting how much of the move has been driven by the latest quarterly results.
- Fiscal Q1 2027 adjusted EPS of $1.55 and revenue of $1.91 billion both exceeded consensus estimates, with the GOJO (Purell) acquisition contributing scale to reported growth.
- Rising input costs remain a key headwind, as management raised its fiscal 2027 inflation forecast to roughly $240 million and signaled adjusted EPS near the low end of its $5.70–$6.00 range.
- Analyst reactions were mixed, with several firms raising price targets while others maintained cautious or sell ratings on the stock.
- For additional detail, explore Clorox's Price Targets, Earnings, and Forecast pages.
- Explore Trending AI Robots to see how AI-driven trading strategies are approaching the market.
Company Overview and Market Position
The Clorox Company operates as a major U.S. consumer packaged goods firm headquartered in Oakland, California. Its lineup covers cleaning and disinfecting items, bags and wraps, cat litter, grilling supplies, dressings, water filtration, and professional hygiene. Core brands include Clorox, Glad, Hidden Valley, Brita, Kingsford, Fresh Step, and, since the April 2026 GOJO Industries acquisition, Purell. More than 80% of sales come from brands that hold first- or second-place positions in their categories, with products reaching consumers across roughly 95 markets. The stock draws attention for its defensive characteristics, established brand strength, and consistent dividend growth history, though investors keep an eye on input-cost pressures and competition from both branded and private-label alternatives.
Stock Price Performance Over the Past 30 Days and Quarter
In the most recent 30-day stretch, CLX posted an advance of about 19%, moving from a close near $83.80 up to $99.96. The bulk of that lift occurred around the fiscal first-quarter earnings release in early November. Over the trailing three months, however, the shares are down roughly 2%, after pressure that carried the price to a 52-week low near $79 in late September and early October. The recent 30-day move therefore marks a sharp recovery inside a broader quarterly downtrend that still sits well below the 52-week high near $129.
What Pushed the 30-Day Advance
The main driver was the fiscal first-quarter 2027 report released in early November. Adjusted EPS came in at $1.55 versus the $1.07 consensus, while revenue reached $1.91 billion against expectations of $1.88 billion. Management highlighted better organic sales trends, market-share gains, cost savings, and favorable timing. The GOJO acquisition added meaningful scale, pushing the combined health and hygiene platform above half of net sales. Several analysts lifted price targets, including updates from Morgan Stanley, UBS, Wells Fargo, and TD Cowen, though Goldman Sachs kept a sell rating with a reduced target. Insider buying also appeared, with a director adding shares in early November. On the other side, management raised its fiscal 2027 inflation estimate to about $240 million and guided adjusted EPS toward the low end of the $5.70–$6.00 range.
Drivers of the Three-Month Performance
The quarterly decline reflects a longer stretch of caution rather than one isolated event. Over the past year the stock has moved lower from its 52-week high amid an ERP system transition that disrupted supply and prompted retailer inventory reductions, softer organic sales, elevated inflation, unfavorable mix, and margin compression. The GOJO deal boosted reported sales but introduced integration costs and a margin headwind. Investors have also weighed the roughly 5% dividend yield against coverage concerns and monitored the planned CEO transition. The late-quarter drop to the 52-week low set up the earnings-driven rebound, even as peers such as Procter & Gamble (PG) and Church & Dwight (CHD) continue to shape the broader staples space.
Key Factors to Watch Going Forward
Input-cost inflation and gross-margin trends will stay central, especially with the updated $240 million forecast and heavier pressure expected in the first half of the fiscal year. Full-year adjusted EPS guidance of $5.70–$6.00, now tilted toward the low end, will be watched for any adjustments. Progress on GOJO integration, organic sales trends once acquisition and ERP effects are removed, dividend coverage, free-cash-flow recovery, and the CEO succession outcome all merit attention. The consumer environment remains challenging with value-focused shoppers and private-label competition in play. Analyst views stay split, so sustained margin improvement and steady demand will matter for holding onto the recent recovery.
Exploring AI-Driven Trading Approaches
I often review how quantitative strategies are positioned in names like this by checking Tickeron’s Trending AI Robots. The section highlights top-performing bots across different timeframes and risk profiles, giving a quick way to see how automated models are interpreting current market conditions without needing to build anything from scratch.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CLX in upward trend: 10-day moving average broke above 50-day moving average on November 03, 2026
The 10-day moving average for CLX crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on CLX as a result. In 41 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 42%.
The Moving Average Convergence Divergence (MACD) for CLX just turned positive on October 05, 2026. Looking at past instances where CLX's MACD turned positive, the stock continued to rise in 22 of 47 cases over the following month. The odds of a continued upward trend are 47%.
CLX moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +0.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLX advanced for three days, in 179 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Aroon Indicator entered an Uptrend today. In 75 of 193 cases where CLX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 39%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
CLX broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 10 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CLX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CLX's P/B Ratio (134.314) is slightly higher than the industry average of (21.731). P/E Ratio (20.739) is within average values for comparable stocks, (16.288). Projected Growth (PEG Ratio) (1.019) is also within normal values, averaging (1.518). Dividend Yield (0.050) settles around the average of (0.032) among similar stocks. P/S Ratio (1.542) is also within normal values, averaging (1.902).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a maker of detergent and cleaning products
Industry HouseholdPersonalCare
Advertisement